Findings from a nationwide, multicenter study led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health suggest that patients with COVID-19 have less chance of developing ...
Convalescent plasma therapy has been explored as a means of delivering passive immunity to patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. By transfusing plasma ...
The US Food and Drug Administration (FDA) and European Commission (EC) recently released guidance on convalescent plasma collected from individuals who have recovered from COVID-19 and which may ...
Findings from a nationwide, multicenter study led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health suggest that patients with COVID-19 have less chance of developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results